Esther BREIJ
15Patents
3h-index
41Co-inventors
56Inventor score
Filing activity: Dec 19, 2008 → May 10, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10544220B2 | Bispecific antibodies against CD3 and CD20 | Chemistry; Metallurgy | 9 | Active |
| US10201607B2 | Antibodies binding AXL | Chemistry; Metallurgy | 4 | Active |
| US8802089B2 | Monoclonal antibodies against CD32B | Chemistry; Metallurgy | 3 | Active |
| US10512688B2 | Antibodies binding AXL | Chemistry; Metallurgy | 2 | Active |
| US10500276B2 | Antibodies binding AXL | Chemistry; Metallurgy | 2 | Active |
| US11008399B2 | Antibodies | Chemistry; Metallurgy | 2 | Active |
| US9663578B2 | Monoclonal antibodies against CD32b | Chemistry; Metallurgy | 1 | Active |
| US11130819B2 | Antibodies | Chemistry; Metallurgy | 1 | Active |
| US10765743B2 | Antibodies binding AXL | Chemistry; Metallurgy | 1 | Active |
| US11814437B2 | Antibodies binding to CD30 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11970544B2 | Antibodies | Chemistry; Metallurgy | 0 | Active |
| US12398214B2 | Binding agents binding to EpCAM and CD137 | Chemistry; Metallurgy | 0 | Active |
| US11261254B1 | Antibodies | Chemistry; Metallurgy | 0 | Active |
| US12410258B2 | Antibodies capable of binding to OX40, variants thereof and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11932693B2 | Monoclonal antibodies directed against programmed death-1 protein and their use in medicine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.